Terumo Neuro
Ronak Dholakia, PhD, is a seasoned professional in the field of bioengineering and biomedical engineering, currently serving as a Sr R&D Manager at Terumo Neuro since September 2015. With extensive experience in neurovascular device research and development, Dholakia has contributed to both early and late-stage projects, specializing in novel brain aneurysm therapies and endovascular clinician training. Previous roles include a Research Assistant/Specialist at Stony Brook University Medical Center, where Dholakia conducted NIH-funded projects involving animal studies and imaging analyses. Dholakia's academic background includes a PhD from Stony Brook University and a Master’s from Marquette University, complemented by a Bachelor’s degree from the University of Mumbai. A strong emphasis on device design, computational modeling, and mentorship highlights Dholakia's commitment to advancing medical technology and training future clinicians.
Terumo Neuro
1 followers
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.